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Background: Gastrointestinal stromal tumor (GIST) is a rare tumor comprising 0.1-0.3% of all gastrointestinal (GI)
malignancies. Stomach followed by small intestine is the most common sites of involvement, implicated in 95% of
the cases. We present a case of GIST complicating a colonic interposition. To the best of the author's knowledge,
this is the first reported case of GIST complicating a colonic interposition.
Case presentation: A 47 year old African American male presented to the emergency department with
intermittent, severe chest pain. Past medical history was significant for alkali (NaOH) ingestion during 1980 for
which esophageal resection and a colonic pull-through was performed. A CXR revealed a widened mediastinum
and CT scan chest revealed showed a large (11.4 × 8.3 × 12.1 cm) vascular mediastinal mass. At endoscopy, a large,
ulcerated, cratered and friable mass was found at 29cm extending to 36cm at which point the lower anastomosis
of the colonic pull through was present. Multiple endoscopic biopsies were obtained which showed that the tumor
was immunoreactive with CD117, CD34 and DOG1 while markers of carcinoma, melanoma and lymphoma were
negative. In light of the pathology report, the immunohistochemistry and the CT scans, the tumor was classified as
a stage 4 GIST of colonic interposition.
Conclusions: GIST can complicate unusual locations such as colonic interposition and should be kept in the
differential diagnosis of such unusual presentations.Background
Gastrointestinal stromal tumor (GIST) is a rare tumor
comprising 0.1-0.3% of all gastrointestinal (GI) malig-
nancies. The most common location of GIST is the
stomach (60%), followed by the small intestine (35%).
On rare occasions, these tumors can also be found in
other regions of the gastrointestinal tract (GIT). Less
than 5% of these tumors originate from the colon, mak-
ing colonic GIST extremely rare [1,2]. Despite the broad
range of clinical presentations, many cases are asymp-
tomatic, making early diagnosis difficult.
Our patient underwent colonic interposition for the
treatment of caustic ingestion and developed a GIST in
this surgical site.* Correspondence: harisriaz73@yahoo.com
2Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland,
Ohio, USA
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reproduction in any medium, provided the orCase presentation
A 47 year old African American male presented to the
emergency department with intermittent, severe chest
pain associated with palpitations and one episode of
vomiting.. The pain started without any preceding event
and persisted for approximately 30 seconds during both
rest and exercise. The patient claimed to use street co-
caine for the treatment of his pain. During the last few
months the patient experienced a 40 pound weight loss.
The patient had no history of cardiac symptoms and had
a good exercise tolerance. Patient’s past medical history
was significant for alkali (NaOH) ingestion during 1980
for which esophageal resection and a colonic pull-
through was performed. Notable aspects of the patient’s
history included a father with a brain tumor, 20 pack
year history of smoking and a regular consumption of
cocaine for chest pain.
On physical examination, the patient was alert, coopera-
tive and in slight distress. His vitals were normal except
for a blood pressure of 147/83. General examinationl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 2 CT scan showing proximity of the mass with the
great vessels.
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erally. Examination of the chest revealed a 4 × 4 cm mid-
line mass which was extremely tender and inspection of
abdomen showed an old surgical scar.
In the emergency room the patient received aspirin
325 mg, morphine 4 mg intravenously and famotidine
20 mg intravenously.
Baseline laboratory tests including complete blood count,
metabolic and coagulation profiles were within normal
limits. An unremarkable electrocardiogram (EKG) and
three sets of negative troponins excluded a cardiac
cause for patient’s chest pain. A Chest X Ray (CXR) re-
vealed a widened mediastinum and a CT Chest was or-
dered which was eventually extended to include the
abdomen and pelvis. This showed a large (11.4 × 8.3 ×
12.1 cm) vascular mediastinal mass (Figure 1).
This mass was in contiguity with the heart, stomach
and aorta, exerting mass effect on the aorta and pul-
monary vasculature (Figure 2).
The CT scan also revealed multiple round enhancing
liver lesions raising the suspicion of a metastatic malig-
nancy with the largest lesion in the left lobe measuring
3.9 cm (Figure 3).
GI and Surgery were consulted and an endoscopy and
EUS were planned. At endoscopy, a large, ulcerated, cra-
tered and friable mass was found at 29 cm extending to
36 cm at which point the lower anastomosis of the co-
lonic pull through was present (Figure 4).
Multiple endoscopic biopsies were obtained and sent
for pathology. Fine needle aspiration was attempted
under EUS guidance to assess the nature of hepatic le-
sions (Figure 5).Figure 1 Chest CT scan showing a mediastinal mass.Pathology of the esophago-gastroduodenoscopy (EGD)
biopsy revealed colonic mucosa with acute and chronic
inflammation, granulation tissue and ulcerative debris.
The fragments were highly atypical with hyperchromasia
and mitotic activity. The FNA from hepatic lesions were
also positive for malignant cells. The immunohistochem-
ical analysis of the EGD biopsy showed that the tumor
was immunoreactive with CD117, CD34 and DOG1
while markers of carcinoma, melanoma and lymphoma
were negative. In light of the pathology report, theFigure 3 CT scan abdomen showing multiple enhancing hepatic
lesions.
Figure 4 Endoscopic visualization of an ulcerated, friable mass.
Figure 6 H and E stained colonic mucosa.
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was classified as a stage 4 GIST of colonic interpos-
ition (Figures 6, 7 and 8).
Subsequent to the biopsy based diagnosis, surgical and
radiological treatment modalities were ruled out due to
the extent and nature of the tumor. The patient was ad-
ministered imatinib 400 orally daily, adequate pain con-
trol medications and a suitable bowel regimen.
Patient continues to do well on 3 months follow up.
Follow CT scan shows considerable shrinkage in the size
of the tumor Figures 9 and 10.
Discussion
The present case apprears to be unique. Despite an ex-
tensive literature search, no previous cases of GIST com-
plicating a colonic interposition have been reported.
Retrosternal coloplasty remains the gold standard for
the management of esophageal reconstruction secondary
to caustic ingestion [3]. Primarily used in the treatment
of esophageal cancer, interposition grafts are routinelyFigure 5 Ultrasound appearance of hepatic lesions.performed. Multiple studies indicate that over 25% of pa-
tients undergoing this surgical procedure develop some
type of complication, including anastomotic leakage, sten-
osis, wound infection, intestinal obstruction and aspiration
pneumonia, among others [4]. Neoplastic lesions compli-
cating a colonic interposition are exceedingly rare. As of
2010, just 10 such cases were reported in the literature.
The majority of lesions were adenocarcinomas or tubular
adenomas [5].
The patient in this report developed a GIST almost 2
decades after the procedure was performed, closely fol-
lowing similar cases in the literature where the interpos-
ition was complicated by a neoplastic lesion after a
decade or more. It is generally believed that patients
with esophageal malignancy have an already dismal prog-
nosis and hence with a reduced life span, the chances toFigure 7 CD117 stained colonic mucosa.
Figure 8 CD117 stained colonic mucosa.
Figure 10 CT scan showing resolution of tumor at 3 months.
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are fairly low.
As the most common mesenchymal neoplasm of the
GI tract, GIST manifests itself inconsistently in patients
and requires immunohistochemical means to establish a
definitive diagnosis. Studies indicate that approximately
95% of the cases are KIT positive which confers the
tumor with proliferative potential as well as the ability to
evade apoptotic pathways [6].
The radiographic features of a colonic GIST mimic
those of leiomyosarcomas, appearing as transmural or
sub-mucosal masses on barium follow through. TheFigure 9 CT scan showing resolution of tumor at 3 months.differential diagnosis also includes adenocarcinoma,
lymphoma, metastatic melanoma and retroperitoneal
sarcoma [7]. A case series of colonic GIST demonstrated
that roughly half the patients with lesions greater than
1 cm, showed evidence of metastasis while one fifth had
hepatic metastastases as evident in the present patient
[7].
The predominant histopathological forms of the tumor
are spindle cell and epitheloid. CD117 (KIT) is the pri-
mary immunological marker, seen in roughly 75% of cases
of colonic GIST (compared with 95% of cases of gastric
origin). Other less frequent immunological markers in-
clude CD34 and alpha smooth muscle actin [8].
Imatinib mesylate, an inhibitor of the tyrosine kinase
signaling pathway is the most effective treatment option.
The disease carries a dismal prognosis in the presence of
overt metastasis. However, the subject patient showed a
dramatic response to imatinib therapy and is doing well
after a three month follow up. Consensus Tumor size
and the presence of numerous mitosis are the most im-
portant determinants affecting prognosis [8].Conclusions
GIST can complicate unusual locations including the co-
lonic interposition and should be included in the differ-
ential diagnosis of such unusual presentations.Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
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